|
1
|
Robert J: Biology of cancer metastasis.
Bull Cancer. 100:333–342. 2013.In French. PubMed/NCBI
|
|
2
|
Guise T: Examining the metastatic niche:
targeting the microenvironment. Semin Oncol. 37(Suppl 2): S2–S14.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Paget S: The distribution of secondary
growths in cancer of the breast. 1889. Cancer Metastasis Rev.
8:98–101. 1989.PubMed/NCBI
|
|
4
|
Patel LR, Camacho DF, Shiozawa Y, Pienta
KJ and Taichman RS: Mechanisms of cancer cell metastasis to the
bone: a multistep process. Future Oncol. 7:1285–1297. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Jemal A, Siegel R, Ward E, Hao Y, Xu J and
Thun MJ: Cancer statistics, 2009. CA Cancer J Clin. 59:225–249.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Miki T, Yano S, Hanibuchi M and Sone S:
Bone metastasis model with multiorgan dissemination of human
small-cell lung cancer (SBC-5) cells in natural killer
cell-depleted SCID mice. Oncol Res. 12:209–217. 2000.
|
|
7
|
Ben-Baruch A: Organ selectivity in
metastasis: regulation by chemokines and their receptors. Clin Exp
Metastasis. 25:345–356. 2008. View Article : Google Scholar
|
|
8
|
Chen JD, Bai X, Yang AG, Cong Y and Chen
SY: Inactivation of HIV-1 chemokine co-receptor CXCR-4 by a novel
intrakine strategy. Nat Med. 3:1110–1116. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Bai X, Chen JD, Yang AG, Torti F and Chen
SY: Genetic co-inactivation of macrophage- and T-tropic HIV-1
chemokine coreceptors CCR-5 and CXCR-4 by intrakines. Gene Ther.
5:984–994. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zhang JC, Sun L, Nie QH, et al:
Down-regulation of CXCR4 expression by SDF-KDEL in CD34(+)
hematopoietic stem cells: An anti-human immunodeficiency virus
strategy. J Virol Methods. 161:30–37. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ma WF, Du J, Fu LP, Fang R, Chen HY and
Cai SH: Phenotypic knockout of CXCR4 by a novel recombinant protein
TAT/54R/KDEL inhibits tumors metastasis. Mol Cancer Res.
7:1613–1621. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Bachelerie F, Ben-Baruch A, Burkhardt AM,
et al: International Union of Basic and Clinical Pharmacology.
#x0005B;corrected]. LXXXIX. Update on the extended family of
chemokine receptors and introducing a new nomenclature for atypical
chemokine receptor. Pharmacol Rev. 66:1–79. 2013. View Article : Google Scholar
|
|
13
|
Hayashi H: A review on the natural
mediators of inflammatory leucotaxis. Acta Pathol Jpn. 32(Suppl 2):
271–284. 1982.PubMed/NCBI
|
|
14
|
Roy I, Evans DB and Dwinell MB: Chemokines
and chemokine receptors: update on utility and challenges for the
clinician. Surgery. 155:961–973. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Cojoc M, Peitzsch C, Trautmann F,
Polishchuk L, Telegeev GD and Dubrovska A: Emerging targets in
cancer management: role of the CXCL12/CXCR4 axis. Onco Targets
Ther. 6:1347–1361. 2013.PubMed/NCBI
|
|
16
|
Phillips RJ, Burdick MD, Lutz M, Belperio
JA, Keane MP and Strieter RM: The stromal derived
factor-1/CXCL12-CXC chemokine receptor 4 biological axis in
non-small cell lung cancer metastases. Am J Respir Crit Care Med.
167:1676–1686. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Gebura K and Bogunia-Kubik K: Clinical
relevance of chemokine receptor CXCR4. Postepy Hig Med Dosw
(Online). 66:252–266. 2012.In Polish. View Article : Google Scholar
|
|
18
|
Hung CS, Su HY, Liang HH, et al:
High-level expression of CXCR4 in breast cancer is associated with
early distant and bone metastases. Tumour Biol. 35:1581–1588. 2014.
View Article : Google Scholar
|
|
19
|
Yang Q, Zhang F, Ding Y, et al: Antitumour
activity of the recombination polypeptide GST-NT21MP is mediated by
inhibition of CXCR4 pathway in breast cancer. Br J Cancer.
110:1288–1297. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhong W, Chen W, Zhang D, et al:
CXCL12/CXCR4 axis plays pivotal roles in the organ-specific
metastasis of pancreatic adenocarcinoma: A clinical study. Exp Ther
Med. 4:363–369. 2012.PubMed/NCBI
|
|
21
|
Toyozawa S, Kaminaka C, Furukawa F,
Nakamura Y, Matsunaka H and Yamamoto Y: Chemokine receptor CXCR4 is
a novel marker for the progression of cutaneous malignant
melanomas. Acta Histochem Cytochem. 45:293–299. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Sun J, Feng C, Liao W, Zhang H and Tang S:
Expression of CXC chemokine receptor-4 and forkhead box 3 in
neuroblastoma cells and response to chemotherapy. Oncol Lett.
7:2083–2088. 2014.PubMed/NCBI
|
|
23
|
Ma M, Ye JY, Deng R, Dee CM and Chan GC:
Mesenchymal stromal cells may enhance metastasis of neuroblastoma
via SDF-1/CXCR4 and SDF-1/CXCR7 signaling. Cancer Lett. 312:1–10.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Wang J, Loberg R and Taichman RS: The
pivotal role of CXCL12 (SDF-1)/CXCR4 axis in bone metastasis.
Cancer Metastasis Rev. 25:573–587. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Hartmann TN, Burger JA, Glodek A, Fujii N
and Burger M: CXCR4 chemokine receptor and integrin signaling
co-operate in mediating adhesion and chemoresistance in small cell
lung cancer (SCLC) cells. Oncogene. 24:4462–4471. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Wang B, Wang W, Niu W, et al: SDF-1/CXCR4
axis promotes directional migration of colorectal cancer cells
through upregulation of integrin αvβ6. Carcinogenesis. 35:282–291.
2014. View Article : Google Scholar
|
|
27
|
Barbieri F, Bajetto A, Porcile C, et al:
CXC receptor and chemokine expression in human meningioma:
SDF1/CXCR4 signaling activates ERK1/2 and stimulates meningioma
cell proliferation. Ann NY Acad Sci. 1090:332–343. 2006. View Article : Google Scholar
|
|
28
|
Wong D and Korz W: Translating an
antagonist of chemokine receptor CXCR4: from bench to bedside. Clin
Cancer Res. 14:7975–7980. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Mimeault M and Batra SK: Hypoxia-inducing
factors as master regulators of stemness properties and altered
metabolism of cancer- and metastasis-initiating cells. J Cell Mol
Med. 17:30–54. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Sun X, Wei L, Chen Q and Terek RM:
CXCR4/SDF1 mediate hypoxia induced chondrosarcoma cell invasion
through ERK signaling and increased MMP1 expression. Mol Cancer.
9:172010. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Guo M, Cai C, Zhao G, et al: Hypoxia
promotes migration and induces CXCR4 expression via HIF-1α a
activation in human osteosarcoma. PLoS One. 9:e905182014.
View Article : Google Scholar
|
